Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 1, 2005, Pages 109-119

  Sidhu, P K ^a   Landoni, M F ^b   Lees, P ^c  

^a PUNJAB AGRICULTURAL UNIVERSITY   (India)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MARBOFLOXACIN; PROSTAGLANDIN E2; THROMBOXANE B2; TOLFENAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; COW; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG SENSITIVITY; ENZYME INHIBITION; EX VIVO STUDY; EXUDATE; IC 50; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SKIN TEMPERATURE;

ANIMALS; ANIMALS, NEWBORN; ANTHRANILIC ACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CATTLE; DIFFUSION CHAMBERS, CULTURE; DNA TOPOISOMERASES, TYPE II; DRUG COMBINATIONS; DRUG INTERACTIONS; FLUOROQUINOLONES; INJECTIONS, INTRAMUSCULAR; MALE; QUINOLONES;

EID: 14844344826     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00633.x     Document Type: Article

References (52)

1. Alanko, J., Moilanen, E., Opas, J. & Vapaatalo, H. (1989) Tolfenamic acid inhibits leukotriene synthesis in human granulocytes. Agents and Actions, 26, 254-255.
2. Benet, L.Z. & Sheiner, L.B. (1985) Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, pp. 3-34. Macmillan Publishing Company. New York.
3. Bousquet-Melou, A., Cester, C.C., Serthelon, J.P., Gruet, P.L. & Toutain, P.L. (1997) Pharmacodynamic study of the potential epileptic effect of combination therapy with marbofloxacin-tolfenamic acid in dog. Journal of Veterinary Pharmacology and Therapeutics. 20 (Suppl. 1 ), 186.
4. Chandrasekharan, N.V., Hu Dai, K., Roos, L.T., Evanson, N.K., Tomsik, J., Elton, T.S. & Simmons, D.S. (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proceedings of the National Academy of Sciences, 99, 13926-13931.
5. Cheng, Z., Welsh, E., Nolan, A. & McKellar, Q.A. (1997) Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats. Veterinary Record, 140, 40-43.
6. Cheng, Z., McKellar, Q.A. & Nolan, A. (1998) Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep. Journal of Veterinary Pharmacology and Therapeutics, 21, 315-321,
7. Dahlstrom, B., Daalzow, L., Segre, G. & Agren, J. (1978) Relationship between morphine pharmacokinetics and analgesia. Journal of Pharmacology and Biopharmaceutics, 6, 41-53.
8. Deleforge, J., Thomas, E., Davot, J.L. & Boisrame, B. (1994) A Held evaluation of the efficacy of tolfenamic acid and oxytetracycline in the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics, 17, 43-47.
9. Fu, J.Y., Masferrer, J.L., Seibert, K., Roz, A. & Needleman, P. (1990) The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. Journal of Biological Chemistry, 265, 16737-16740.
10. Hardie, E.M., Hardee, G.E. & Rawlings, C.A. (1985) Pharmacokinetics of flunixin meglumine in dogs. American Journal of Veterinary Research, 46, 235-237.
11. Higgins, A.J. & Lees, P. (1984a) The acute inflammatory process, arachidonic acid metabolism and mode of action of non-steroidal antiinflammatory drugs. Equine Veterinary Journal, 16, 163-175.
12. Higgins, A.J. & Lees, P. (1984b) Arachidonic acid metabolites in carrageenan-induced equine inflammatory exudate. Journal of Veterinary Pharmacology and Therapeutics, 7, 65-72.
13. Higgins, A.J., Lees, P. & Wright, J.A. (1984) Tissue cage model for collection of inflammatory exudate in ponies. Research in Veterinary Science, 36, 284-289.
14. Holford, N. & Sheiner, L. (1981) Understanding the dose-effect relationship: clinical application to pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics, 6, 429-453.
15. Holford, N. & Sheiner, L. (1982) Kinetics of pharmacological response. Pharmacology and Therapeutics, 16, 143-166.
16. Intorre, L., Menbozzi, G., Maccheroni, M., Bertini, S. & Soldant, G. (1995) Influence of enrofloxacin on theophylline steady-state pharmacokinetics in the Beagle dog. Journal of Veterinary Pharmacology and Therapeutics, 18, 352-356.
17. Jaussaud, P., Guieu, D., Bellon, C., Barbier, B., Lhopital, M.C., Sechet, R., Courtot, D. & Toutain, P.L. (1991) Pharmacokinetics of tolfenamic acid in the horse. Equine Veterinary Journal, 23, 69-72.
18. Kujubu, D.A., Fletcher, B.S., Varnum, B.C., Lim, R.W. & Herschman, H. (1991) TLS10, a phorbal ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxy-genase homologue. Journal of Biological Chemistry, 266, 12866-12872.
19. Landoni, M.F. & Lees, P. (1995a) Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves. Chirality, 7, 586-597.
20. Landoni, M.F. & Lees, P. (1995b) Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modeling. Equine Veterinary Journal, 27, 247-256.
21. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995a) Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modelling. American Journal of Veterinary Research, 56, 786-794.
22. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995b) Comparative pharmacodynamics of flunixin, ketoprofen and tolfenamic acid in calves. Veterinary Record, 137, 428-431.
23. Landoni, M.F., Cunningham, F.M. & Lees, P. (1996) Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. Research in Veterinary Science, 61, 26-32.
24. Lees, P. (2003) Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology, 11, 385-399.
25. Lees, P., Taylor, J.B.O., Higgins, A.J. & Sharma, S.C. (1986) Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse. Journal of Veterinary Pharmacology and Therapeutics, 9, 204-212.
26. Lees, P., Higgins, A.J., Sedgwick, A.D. & May, S.A. (1987) Applications of equine models of acute inflammation. Veterinary Record, 120, 522-529.
27. Lees, P., Delatour, P., Benoit, E. & Foster, A.P. (1991) Pharmacokinetics of carprofen enantiomers in the horse. Acta Veterinaria Scandinavia, 87, 249-251.
28. Lees, P., McKellar, Q.A., Foot, R. & Gettinby, G. (1998) Pharmacodynamics and pharmacokinetics of tolfenamic acid in ruminating calves: evaluation in models of acute inflammation. Veterinary Journal, 155, 275-288.
29. Lefebvre, H.P., Laroute, V., Alvinerie, M., Schneider, M., Vinclair, P., Braun, J.P. & Toutain, P.L. (1997) The effect of experimental renal failure on tolfenamic acid disposition in the dog. Biopharmaceutics and Drug Disposition, 18, 79-91.
30. Linden, I.E., Parantainen, J., Karppanen, H. & Vapaatalo, H. (1975) Inhibitory effects of tolfenamic acid, indomethacin and acetylsalicylic acid on prostaglandin synthetase and phospho-diesterase in vitro. Sixth International Congress of Pharmacology. Helsinki. Finland. July 20-25. Abstract no. 594.
31. Linden, I.B., Parantainen, J. & Vapaatalo, H. (1976) Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro. Scandinavian Journal of Rheumatology, 5, 129-132.
32. McKellar, Q.A., Galbraith, E.A. & Simmons, R.D. (1991) Pharmacokinetics and serum thromboxane inhibition of two NSAIDs when administered to dogs by intravenous or subcutaneous route. Journal of Small Animal Practice, 32, 225-235.
33. McKellar, Q.A., Lees, P. & Gettinby, G. (1994a) Pharmacodynamics of tolfenamic acid in dogs. Evaluation of dose response relationship. European Journal of Pharmacology, 253, 191-200.
34. McKellar, Q.A., Delatour, P. & Lees, P. (1994b) Stereospecific pharmacodynamics and pharmacokinetics of carprofen in the dog. Journal of Veterinary Pharmacology and Therapeutics, 17, 447-454.
35. Meade, E., Smith, W. & DeWitt, D. (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. Journal of Biological Chemistry, 268, 6610-6614.
36. Moilanen, E., Alanko, J., Juhakoski, A. & Vapaatalo, H. (1989) Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leucocytes. Agents and Actions, 28, 83-88.
37. Neer, T.M. (1988) Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. Journal of the American Veterinary Medicine Association, 193, 577-580.
38. Pentikainen, P.J., Neuvonen, P.J. & Backman, C. (1981) Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. European Journal of Clinical Pharmacology, 19, 359-365.
39. Pentikainen, P.J., Tokola, O., Alhava, E. & Penttila, A. (1984) Pharmacokinetics of tolfenamic acid. Disposition in bile, blood and urine after intravenous administration to man. European Journal of Clinical Pharmacology, 27, 349-354.
40. Priymenko, N., Ferre, J.P., Rascol, A., Costes, G. & Toutain, P.L. (1993) Migrating motor complex of the intestine and absorption of a biliary excreted drug in the dog. Journal of Pharmacology and Experimental Therapeutics, 267, 1161-1167.
41. Proudman, K.E. & McMillan, R.M. (1991) Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclooxygenase. Agents and Actions, 34, 121-124.
42. Sheiner, L., Stanki, D., Miller, R. & Ham, J. (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clinical Pharmacology, 25, 358-371.
43. Sidhu, P.K., Aliabadi, P.S., Andrews, M. & Lees, P. (2003) Tissue chamber model of acute inflammation in farm animal species. Research in Veterinary Science, 74, 67-77.
44. Soback, S., Gips, M. & Bialer, M. (1994) Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves, 6th EAVPT Congress Proceedings, pp. 63-64. Blackwell Scientific Publications, Edinburgh, UK.
45. Sullins, K.E., Messer, N.T. & Nelson, L. (1984) Serum concentrations of penicillin in the horse after repeated intramuscular injections of procaine penicillin alone or in combination with phenylbutazone. American Journal of Veterinary Research, 45, 1003-1007.
46. Vane, J.R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature, 231, 232-235.
47. Warner, T.D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J.A. & Vane, J.R. (1999) Non-steroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences, 96, 7563-7568.
48. Wasfi, I.A., ElGhazali, M. & Hadi, A.A.A. (1998) Pharmacokinetics of tolfenamic acid and its detection time in urine after intravenous administration of the drug in camels (Camelus dromedaruis). American Journal of Veterinary Research, 59, 1451-1458.
49. Whittem, T., Firth, B.C., Hodge, H. & Turner, K. (1996) Pharmacokinetic interactions between repeated dose phenylbutazone and gentamicin in the horse. Journal of Veterinary Pharmacology and Therapeutics, 19, 454-459.
50. Wolfson, J.S. & Hooper, D.C. (1989) Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews, 2, 378-424.
51. Wolfson, J.S. & Hooper, D.C. (1991) Pharmacokinetics of quinolones: newer aspects, European journal of Clinical Microbiology and Infectious Diseases, 10, 267-274.
52. Xie, W., Chipman, J.G., Robertson, D., Erikson, R.L. & Simmons, P.L. (1991) Expression of a mitogen responsive gene encoding pros-taglandin synthase is regulated by MRNA splicing. Proceedings of the National Academy of Sciences, 88, 2692-2696.